trending Market Intelligence /marketintelligence/en/news-insights/trending/f2AW7wLbpmfYCq3Ii_0TcQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Aphria closes acquisition of Germany's CC Pharma

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Aphria closes acquisition of Germany's CC Pharma

Canadian cannabis company Aphria Inc. completed its previously announced acquisition of Germany-based pharmaceutical distributor CC Pharma GmbH.

Upon closing, former CC Pharma shareholders were paid with €18.9 million cash. They may also receive up to €23.5 million after closing if certain performance milestones are met.

The acquisition is part of Aphria's expansion efforts in Germany and to ultimately establish a pan-European platform incorporating demand, supply and distribution.